Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05364606Recruiting

Patient Specific Talus Spacer Post Approval Study

Role: lead

NCT04893824Completed

Grappler® Interference Screw Post-Market Clinical Follow-Up Study

Role: lead

NCT05190159Completed

Monster Screw System Post-Market Clinical Follow-Up Study

Role: lead

NCT04084262Completed

Multi-Plane Hallux Valgus Correction With the Phantom® Nail

Role: lead

NCT05190874Completed

Grappler Interference Screw Post-Market Collection of Patient Reported Outcome Measures

Role: lead

NCT03619382Completed

An Evaluation Of Healthy Ankle Motion And Morphology

Role: lead

NCT03257540Terminated

Early Weight-Bearing After Lapidus Arthrodesis

Role: lead

NCT03421665Withdrawn

Evaluation of the Titan 3-D™ Wedge System

Role: lead

All 8 trials loaded